EarningsQ4 2022 Earnings Report

ANI Pharmaceuticals (BSFA) Q4 2022 Earnings Report

0 Followers

CH:BSFA Q4 2022 EPS Results

Actual EPSCHF0.63

Consensus EPSCHF0.56

Beat/MissBeat by +CHF0.07

One Year Ago EPSCHF0.45

Actual RevenueCHF78.52M

Expected RevenueCHF71.69M

Beat/MissBeat by +CHF6.83M

YoY Revenue Growth+54.66%

QuarterQ4 2022

Date03/09/2023

TimeBefore Open

Conference CallThursday, March 9, 2023

CH:BSFA Upcoming Earnings

ANI Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

CH:BSFA Q4 2022 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	1.82 / -	1.7	―
Aug 07, 2026	2026 (Q2)	1.70 / 1.84	1.5	22.78% (+0.34)
May 08, 2026	2026 (Q1)	1.08 / 1.71	1.417	20.59% (+0.29)
Mar 03, 2026	2025 (Q4)	1.66 / 1.94	1.358	42.94% (+0.58)
Nov 10, 2025	2025 (Q3)	1.47 / 1.70	1.117	52.24% (+0.58)
Aug 08, 2025	2025 (Q2)	1.17 / 1.50	0.85	76.47% (+0.65)
May 09, 2025	2025 (Q1)	1.15 / 1.42	1.008	40.50% (+0.41)
Feb 28, 2025	2024 (Q4)	1.20 / 1.36	0.833	63.00% (+0.52)
Nov 08, 2024	2024 (Q3)	0.90 / 1.12	1.058	5.51% (+0.06)
Aug 06, 2024	2024 (Q2)	0.79 / 0.85	1.067	-20.31% (-0.22)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed